Chronic, recurrent Lymphocytic Leukemia Completed Phase 2 Trials for Mechlorethamine (DB00888)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01008462Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaTreatment